e-learning
resources
Milan 2017
Sunday, 10.09.2017
Paediatric asthma: therapies and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cost of sublingual bacterial vaccines in the treatment of asthma in children.
A. Bodajko-Grochowska (Lublin, Poland)
Source:
International Congress 2017 – Paediatric asthma: therapies and comorbidities
Session:
Paediatric asthma: therapies and comorbidities
Session type:
Thematic Poster
Number:
1314
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bodajko-Grochowska (Lublin, Poland). Cost of sublingual bacterial vaccines in the treatment of asthma in children.. 1314
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Cost implications for the introduction of omalizumab in to the management of severe chronic asthma in children
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006
Cost effectiveness of omalizumab in Swedish asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 441s
Year: 2006
The importance of pneumococcal and influenza vaccines in patients with allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 376s
Year: 2005
Safety of omalizumab therapy in children with allergic asthma
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009
Cost effectiveness of bronchial thermoplasty for treatment of severe asthma patients in spain
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
Efficacy of the long-term therapy with simbicort in children with bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 395s
Year: 2005
Safety and efficacy of omalizumab in children with allergic asthma
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011
Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13)
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Clinical efficacy of pneumococcal conjugate vaccine in patients with chronic airway disease
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
Oral immunotherapy in preventing exacerbations of COPD
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Comparison of efficacy of grippe vaccination and broncho vaxom administration in COPD patients
Source: International Congress 2015 – Different data in COPD
Year: 2015
Response of children with bronchial asthma to combined therapy with an oral immunostimulating drug and antileukotrienes
Source: Eur Respir J 2005; 26: Suppl. 49, 159s
Year: 2005
Cost of asthma rescue/acute and allergy medications among asthmatic patients on controller therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004
Meta-analysis of inhaled corticosteroids response in children with asthma.
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019
Severe asthma and biologic therapies during COVID-19: supporting patients care with home administration of mepolizumab and omalizumab
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Effects of oromucosal immunotherapy (SLIT) in children with respiratory allergy
Source: Eur Respir J 2002; 20: Suppl. 38, 525s
Year: 2002
Cost analysis for patients with severe asthma receiving omalizumab treatment
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
Estimate of asthma control and adherence to inhaled corticosteroids in children with asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010
Comparison of efficacy of grippe vaccination in asthma and COPD patients
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011
Impact vaccination against pneumococcal infection for clinical-functional indexes and course of bronchial asthma in children
Source: Eur Respir J 2004; 24: Suppl. 48, 611s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept